
Dizigo 25mg Tablet
Marketer
Medisun Pharma
Salt Composition
Cinnarizine (25mg)
Overview Dizigo 25mg Tablet
Histamine blocker, VertiGone 25mg tablets, effectively manage motion sickness, vertigo, and Meniere's disease symptoms. To minimize stomach upset, consume with food. Follow your physician's prescribed dosage, ideally at consistent intervals daily. Missed doses should be taken immediately upon recall; complete the entire treatment regimen; never discontinue abruptly without consulting your doctor. Somnolence, nausea, and potential weight gain are possible side effects. Refrain from operating machinery or engaging in activities demanding concentration until the drug's effects are known. Weight gain can be mitigated by a nutritious diet, limiting high-calorie snacks, and regular physical activity. Prior to use, disclose any existing peptic ulcers, asthma, or hypotension to your doctor. Report concurrent medication use to your doctor, as interactions may alter efficacy. Pregnant or lactating individuals require medical consultation before initiating treatment.
Uses of Dizigo 25mg Tablet
Managing motion sickness, vertigo, and Meniere's disease.
Major Benefits of Dizigo 25mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dizigo 25mg tablets should be administered with a meal.
Common Side effects of Dizigo 25mg Tablet:
- Sleepiness
- Nausea
- Weight gain
How to use Dizigo 25mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 25mg Dizigo tablet whole; do not chew, crush, or divide it. It should be taken with a meal.
How Dizigo 25mg Tablet works:
Dizigo 25mg tablets alleviate inner ear blood vessel constriction, thereby enhancing microcirculation in the ear.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Dizigo 25mg tablets and alcohol may induce significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Dizigo 25mg Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescription. Consult your doctor for advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Dizigo 25mg Tablet while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking a 25mg Dizigo tablet may cause drowsiness, blurred vision, or dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data on Dizigo 25mg Tablet use in patients with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Dizigo 25mg tablets to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Dizigo 25mg Tablet :
Should you forget a Dizigo 25mg Tablet dose, administer it promptly. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dizigo 25mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Piperazine-based compound |
| Developing Habits | No. |
| Treatment Category | Neuroscience (CNS) |
